Q3 2026 13F filing
Updated 6 days ago55 disclosed positions worth $153M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GUARDANT HEALTH INC | $12M | 67.5K | 7.87% | — |
| 2 | T TG THERAPEUTICS INC | $10.5M | 187.7K | 6.84% | — |
| 3 | A ABIVAX SA | $9M | 90.9K | 5.88% | — |
| 4 | P PRAXIS PRECISION MEDICINES I | $8.6M | 29.7K | 5.65% | — |
| 5 | C COGENT BIOSCIENCES INC | $6.7M | 210.5K | 4.41% | — |
| 6 | L ELI LILLY & CO | $6.4M | 5.5K | 4.15% | — |
| 7 | N NATERA INC | $5.7M | 13.8K | 3.73% | — |
| 8 | V VERA THERAPEUTICS INC | $5.2M | 159.6K | 3.37% | — |
| 9 | V VIKING THERAPEUTICS INC | $4.8M | 147.5K | 3.14% | — |
| 10 | I IONIS PHARMACEUTICALS INC | $4.8M | 107.0K | 3.12% | — |
| 11 | E ENLIVEN THERAPEUTICS INC | $4.6M | 100.2K | 3.00% | — |
| 12 | C CARIS LIFE SCIENCES INC | $4.5M | 146.1K | 2.92% | — |
| 13 | N NEKTAR THERAPEUTICS | $4.5M | 73.7K | 2.92% | — |
| 14 | C CYTOKINETICS INC | $4M | 60.1K | 2.59% | — |
| 15 | V VERASTEM INC | $3.5M | 429.0K | 2.26% | — |
| 16 | M MAZE THERAPEUTICS INC | $3.1M | 114.7K | 2.04% | — |
| 17 | R RHYTHM PHARMACEUTICALS INC | $3.1M | 32.2K | 2.00% | — |
| 18 | T 10X GENOMICS INC | $2.7M | 30.1K | 1.78% | — |
| 19 | A ALKERMES PLC | $2.5M | 61.3K | 1.62% | — |
| 20 | U UNITED THERAPEUTICS CORP DEL | $2.2M | 4.1K | 1.46% | — |
| 21 | B BOSTON SCIENTIFIC CORP | $2.1M | 48.3K | 1.38% | — |
| 22 | A ARROWHEAD PHARMACEUTICALS IN | $2.1M | 32.2K | 1.38% | — |
| 23 | U UNITEDHEALTH GROUP INC | $2.1M | 5.7K | 1.37% | — |
| 24 | O OCULAR THERAPEUTIX INC | $2.1M | 272.0K | 1.36% | — |
| 25 | A ALUMIS INC | $2.1M | 282.3K | 1.36% | — |
| 26 | P PENUMBRA INC | $2M | 6.3K | 1.31% | — |
| 27 | I INTUITIVE SURGICAL INC | $2M | 4.9K | 1.30% | — |
| 28 | M MOONLAKE IMMUNOTHERAPEUTICS | $1.9M | 166.5K | 1.27% | — |
| 29 | C COMPASS PATHWAYS PLC | $1.9M | 153.1K | 1.24% | — |
| 30 | C CELLDEX THERAPEUTICS INC NEW | $1.8M | 56.3K | 1.19% | — |
| 31 | M MERCK & CO INC | $1.8M | 12.4K | 1.17% | — |
| 32 | L LIQUIDIA CORPORATION | $1.8M | 59.2K | 1.17% | — |
| 33 | G GLAUKOS CORP | $1.8M | 10.9K | 1.17% | — |
| 34 | M MONTE ROSA THERAPEUTICS INC | $1.6M | 137.0K | 1.07% | — |
| 35 | B BRIDGEBIO PHARMA INC | $1.4M | 21.2K | 0.91% | — |
| 36 | C CLEARPOINT NEURO INC | $1.3M | 110.2K | 0.88% | — |
| 37 | C CORBUS PHARMACEUTICALS HLDGS | $1.3M | 190.7K | 0.85% | — |
| 38 | C CYTOMX THERAPEUTICS INC. | $1.3M | 460.1K | 0.82% | — |
| 39 | P PALVELLA THERAPEUTICS INC NE | $1.1M | 7.8K | 0.70% | — |
| 40 | A ASCENDIS PHARMA A/S | $1M | 4.4K | 0.66% | — |
| 41 | R RAPPORT THERAPEUTICS INC | $987K | 29.4K | 0.65% | — |
| 42 | B BILLIONTOONE INC | $956K | 9.0K | 0.62% | — |
| 43 | Z ZENAS BIOPHARMA INC | $926K | 34.3K | 0.61% | — |
| 44 | Q REPLIMUNE GROUP INC | $907K | 68.5K | 0.59% | — |
| 45 | ? N/A EQUILLIUM INC | $899K | 553.0K | 0.59% | — |
| 46 | E ESTABLISHMENT LABS HLDGS INC | $841K | 13.1K | 0.55% | — |
| 47 | ? N/A CLIMB BIO INC | $817K | 71.2K | 0.53% | — |
| 48 | N NOVABRIDGE BIOSCIENCES | $788K | 577.0K | 0.51% | — |
| 49 | D BRIGHT MINDS BIOSCIENCES INC | $733K | 14.7K | 0.48% | — |
| 50 | ? N/A COMPASS THERAPEUTICS INC | $532K | 511.1K | 0.35% | — |